NFKB1 and chronic myelogenous leukemia, BCR-ABL1 positive: The importance of these transcription factors in CML has been highlighted by the fact that NF-κB is activated in transgenic models of CML and that Bcr-Abl can activate NF-κB (Kaminska et al., 2008).